BPC-157 + TB-500 Stack vs TB-500
A neutral, side-by-side comparison of two healing & recovery peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.
BPC-157 + TB-500 Stack
The most widely researched peptide stack for tissue repair, combining BPC-157 (angiogenesis and growth factor upregulation) with TB-500 (actin regulation and cell migration). The two compounds address complementary and non-overlapping stages of the healing cascade, producing synergistic effects in tendon, ligament, muscle, and gut injury research models.
Full profileTB-500
TB-500 is a synthetic fragment of Thymosin Beta-4, an endogenous protein involved in cell migration, tissue repair, and inflammation regulation. It has shown significant healing properties in preclinical models across muscle, tendon, ligament, and cardiac tissue.
Full profile| BPC-157 + TB-500 Stack | TB-500 | |
|---|---|---|
| Category | Healing & Recovery | Healing & Recovery |
| Also known as | Wolverine Stack, BPC TB500 combination, healing stack, BPC-157 TB-500 | Thymosin Beta-4, Tβ4, TB500 |
| Evidence | Research-stage | Preclinical only |
| Dosing range | BPC-157 250mcg + TB-500 2.5mg–BPC-157 750mcg + TB-500 7.5mg varies by component, 2–3x per week | 2mg–10mg mg, twice weekly (loading), weekly (maintenance) |
| Administration | Subcutaneous injection, Intramuscular injection | Subcutaneous injection, Intramuscular injection |
| Key side effects | BPC-157: nausea (rare), dizziness, lightheadedness, TB-500: fatigue, headache, injection site reactions, No documented combination-specific adverse effects, Theoretical oncological considerations (angiogenesis stimulation) — relevant in cancer history | Head rush / lightheadedness (transient), Lethargy at higher doses, Injection site discomfort, Nausea (rare) |
| Cited sources | 2 references | 2 references |
Key differences
- Evidence level differs: BPC-157 + TB-500 Stack is research-stage, while TB-500 is preclinical only.
- Dosing units differ: BPC-157 + TB-500 Stack is dosed in varies by component, TB-500 in mg — they operate at different scales.
- Frequency: BPC-157 + TB-500 Stack is typically 2–3x per week; TB-500 is twice weekly (loading), weekly (maintenance).
How each works
BPC-157 + TB-500 Stack
BPC-157 and TB-500 work through entirely non-overlapping mechanisms and have been combined in numerous community protocols for injury recovery. BPC-157 drives angiogenesis and growth factor receptor expression; TB-500 regulates actin polymerization and cell migration into the injury site. No documented negative interactions exist — the combination is considered synergistic in the healing research community based on the complementary biology of each compound.
TB-500
TB-500 promotes healing by upregulating actin, which drives cell migration to injury sites. Animal studies show accelerated repair of muscle tears, tendon injuries, and corneal wounds. It also demonstrates anti-inflammatory properties and has been studied for cardiac tissue repair following ischemic injury.
This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.